CoChat

Angiotensin‐Converting Enzyme Inhibitors and Alzheimer's Disease Progression in Older Adults: Results from the Réseau sur la Maladie d'Alzheimer Français Cohort

Soto, Maria E., Abellan van Kan, Gabor, Nourhashemi, Fati, Gillette‐Guyonnet, Sophie, Cesari, Matteo, Cantet, Christelle, Rolland, Yves, Vellas, Bruno · 2013 · Journal of the American Geriatrics Society
Cited by 80

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objectives: To assess whether angiotensin‐converting enzyme inhibitor ( ACE ‐I) treatment is associated with less cognitive decline in older adults with Alzheimer's disease ( AD ) than in those using other hypertensive or no drugs. Design: Four‐year prospective multicenter cohort study with a biannual assessment. Setting: Memory clinics from 16 university hospitals in France. Participants: Community‐dwelling older adults with mild to moderate AD (N = 616). Measurements: Participants were stratified into four groups according to type and duration of antihypertensive drug treatment. Cognitive decline was assessed using the Mini‐Mental State Examination ( MMSE ). Linear mixed‐effects models were used to assess differences in decline in MMSE score between the four groups. Hypertension at each visit was included in the model. Results: Sixty‐one participants had used ACE ‐Is continuously, 57 had used them intermittently, 189 had used other antihypertensive drugs, and 309 never used any antihypertensive drugs. Continuous ACE ‐Is users had a 4‐year decline in MMSE of 6.4 ± 1.6 points ( P < .001), intermittent ACE ‐Is users of 7.9 ± 1.1 points ( P < .001), continuous or intermittent users of other antihypertensive drugs of 8.8 ± 0.7 points ( P < .001), and never‐users of 10.2 ± 0.6 points ( P < .001). MMSE decline between the four groups was significantly different (adjusted P = .02). In subgroup analysis, the 118 (19.2%) participants who had continuously or intermittently used ACE ‐Is had a significant difference in 4‐year MMSE decline from the 498 (80.8%) who had never used ACE ‐Is (7.5 ± 0.9 vs 9.7 ± 0.4; P = .03). Conclusion: The use of ACE ‐Is in older adults with AD is associated with a slower rate of cognitive decline independent of hypertension. Future research is needed to explore the role of ACE ‐Is in long‐term AD progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgs.12415

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 80

Metadata

Authors
Soto, M. E., Abellan van Kan, G., Nourhashemi, F., Gillette‐Guyonnet, S., Cesari, M., Cantet, C., Rolland, Y., & Vellas, B.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2013-09
Volume
61
Issue
9
Pages
1482-1488
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2054031839
Cited by
80
References
4
FWCI
4.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.